Biotech · Private company · Saint Louis, MO, US
Certara
Track this companyFree. Adds Certara to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials1
- Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.PHASE1 · RECRUITING · started Oct 20, 2022ClinicalTrials.gov NCT05547321 · fetched Nov 12, 2026
NIH awards4
- Small Molecules and Biologics Toxicology Consultant Support Services Fiscal year 2026 · $179.7KNIH RePORTER 75N95025P00426-P00001-0-1 · fetched Nov 12, 2026
- NINDS, NIH BPN, NIH HEAL AND OTHER NIH NEUROSCIENCE-FOCUSED DRUG DISCOVERY AND DEVELOPMENT PROGRAMS WITH TOXICOLOGY CONSULTING SERVICESFiscal year 2025 · $45KNIH RePORTER 75N95022P00647-P00004-0-1 · fetched Nov 12, 2026
- Small Molecules and Biologics Toxicology Consultant Support Services Fiscal year 2025 · $20.8KNIH RePORTER 75N95025P00426-0-0-1 · fetched Nov 12, 2026
- NINDS, NIH BPN, NIH HEAL AND OTHER NIH NEUROSCIENCE-FOCUSED DRUG DISCOVERY AND DEVELOPMENT PROGRAMS WITH TOXICOLOGY CONSULTING SERVICESFiscal year 2024 · $160.2KNIH RePORTER 75N95022P00647-P00003-0-1 · fetched Nov 12, 2026